HyperglycemiaHypoglycemiaBlood GlucoseDiabetic KetoacidosisGlucose Metabolism DisordersInsulinDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetes MellitusIslets of LangerhansSagittal Abdominal DiameterPrediabetic StateRisk FactorsGlucose IntoleranceGlucose Tolerance TestHemoglobin A, GlycosylatedHypoglycemic AgentsTasmaniaCohort StudiesRiskDiabetes Mellitus, Type 1Case-Control StudiesGlucagonGlucoseFastingSwedenHyperinsulinismIncidenceRisk AssessmentTime FactorsInsulin ResistanceGlucose Clamp TechniqueCardiovascular DiseasesEpinephrineOdds RatioProportional Hazards ModelsAge FactorsProspective StudiesBlood Glucose Self-MonitoringFollow-Up StudiesInsulin Infusion SystemsPancreatic PolypeptidePregnancyInfant, NewbornRetrospective StudiesInsulin, Long-ActingSmokingLogistic ModelsEpisode of CareC-PeptideInsulin ComaStreptozocinPrevalenceClinical AlarmsObesityGluconeogenesisROC CurvePredictive Value of TestsVentromedial Hypothalamic NucleusSulfonylurea CompoundsLife StyleNesidioblastosisPostprandial PeriodHydrocortisoneInsulinomaCongenital HyperinsulinismBreast NeoplasmsCross-Sectional StudiesInsulin-Secreting CellsPancreas, ArtificialGlipizideMass ScreeningGlucokinaseDiabetes ComplicationsNorepinephrinePregnancy in DiabeticsHomeostasisRats, Sprague-DawleyFatty Acids, NonesterifiedTreatment OutcomeDiabetic AngiopathiesDiazoxideCritical IllnessGlucagon-Like Peptide 13-Hydroxybutyric AcidLiverInsulin AntibodiesInfusions, IntravenousGlycosuriaInsulin LisproInsulin AspartInsulin, IsophaneMonitoring, AmbulatoryPancreasInfusions, SubcutaneousPhlorhizinMetforminPancreatectomyReference ValuesAwareness